Prion diseases are a group of fatal age-dependent neurodegenerative diseases that can arise spontaneously or be inherited, but can also be infectious. The possibility of spontaneous emergence and the pandemic spread of new prion strains and the transmission and adaptation of existing strains to new hosts including humans are of great concern to public health. Little is known about the molecular aspects of how prions originate and evolve in animals and humans or the principles that underlie the evolution of prion strains. Prion strains exhibit a high level of conformational plasticity and are prone to 'mutation' when transmitted to a new host.
Specific Aim 1 will investigate the mechanism of prion genesis and evolution and test the new hypothesis that transmissible prion diseases can be induced by amyloid structures fundamentally different from that of PrPSc.
Specific Aims 2 will take advantage of new models of prion diseases generated in our laboratory for elucidating the pathological events that lead to clinical prion disease and for exploring factors responsible for strain-specific neurotropism.
Specific Aim 3 will elucidate mechanisms responsible for prion strain 'mutations' and adaptation. Specifically, this aim will test whether a change in the co-factor environment of prion replication leads to a stable change in PrPSc properties and new disease phenotypes and (ii) whether changes in the co-factor environment affect the fate of prion adaptation upon crossing the species barrier. This study will take place in the environment of a medical school, will exploit novel experimental models of prion diseases developed by the PI, and will take advantage of collaborations with internationally known experts on prion pathology. When accomplished, the results from this study will lay the groundwork for understanding the mechanisms of genesis and evolution of infectious protein states and transform our understanding of the mechanisms responsible for adaptation and mutation of prion strains.
Prion diseases are a group of fatal age-dependent neurodegenerative diseases that can arise spontaneously or be inherited, and can also be infectious. Little is known about molecular aspects of how prions originate and evolve in animals and humans, or principles that underlie evolution of prion strains. The current project seeks to elucidate molecular mechanisms underlying prion genesis, evolution, their adaptation and mutation.
| Srivastava, Saurabh; Katorcha, Elizaveta; Makarava, Natallia et al. (2018) Inflammatory response of microglia to prions is controlled by sialylation of PrPSc. Sci Rep 8:11326 |
| Katorcha, Elizaveta; Gonzalez-Montalban, Nuria; Makarava, Natallia et al. (2018) Prion replication environment defines the fate of prion strain adaptation. PLoS Pathog 14:e1007093 |
| Katorcha, Elizaveta; Baskakov, Ilia V (2018) Analysis of Covalent Modifications of Amyloidogenic Proteins Using Two-Dimensional Electrophoresis: Prion Protein and Its Sialylation. Methods Mol Biol 1779:241-255 |
| Makarava, Natallia; Savtchenko, Regina; Lasch, Peter et al. (2018) Preserving prion strain identity upon replication of prions in vitro using recombinant prion protein. Acta Neuropathol Commun 6:92 |
| Srivastava, Saurabh; Katorcha, Elizaveta; Daus, Martin L et al. (2017) Sialylation Controls Prion Fate in Vivo. J Biol Chem 292:2359-2368 |
| Makarava, Natallia; Savtchenko, Regina; Baskakov, Ilia V (2017) Methods of Protein Misfolding Cyclic Amplification. Methods Mol Biol 1658:169-183 |
| Katorcha, Elizaveta; Baskakov, Ilia V (2017) Analyses of N-linked glycans of PrPSc revealed predominantly 2,6-linked sialic acid residues. FEBS J 284:3727-3738 |
| Makarava, Natallia; Savtchenko, Regina; Baskakov, Ilia V (2017) Purification and Fibrillation of Full-Length Recombinant PrP. Methods Mol Biol 1658:3-22 |
| Baskakov, Ilia V (2017) Limited understanding of the functional diversity of N-linked glycans as a major gap of prion biology. Prion 11:82-88 |
| Katorcha, Elizaveta; Daus, Martin L; Gonzalez-Montalban, Nuria et al. (2016) Reversible off and on switching of prion infectivity via removing and reinstalling prion sialylation. Sci Rep 6:33119 |
Showing the most recent 10 out of 67 publications
